Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial-Reference-Cited by-同舟云学术

Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

Published:2015-05-15 Issue:12 Volume:29 Page:2438-2441
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tokumasu M,Murata C,Shimada A,Ohki K,Hayashi Y,Saito A M,Fujimoto J,Horibe K,Nagao M,Itoh H,Kamikubo Y,Nakayama H,Kinoshita A,Tomizawa D,Taga T,Tawa A,Tanaka S,Heike T,Adachi S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015121.pdf

Reference16 articles.

1. Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T et al. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia 2013; 27: 2413–2416.

2. Lennartsson J, Ronnstrand L . Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev 2012; 92: 1619–1649.

3. Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 2006; 107: 3463–3468.

4. Schnittger S, Kohl TM, Haferlach T, Kern W, Hiddemann W, Spiekermann K et al. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. Blood 2006; 107: 1791–1799.

5. Allen C, Hills RK, Lamb K, Evans C, Tinsley S, Sellar R et al. The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia 2013; 27: 1891–1901.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1;Pediatric Blood & Cancer;2023-11-28

2. Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16);BMC Cancer;2023-05-25

3. Comprehensive molecular understanding of pediatric acute myeloid leukemia;International Journal of Hematology;2023-01-18

4. Droplet digital PCR for genetic mutations monitoring predicts relapse risk in pediatric acute myeloid leukemia;International Journal of Hematology;2022-07-18

5. Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia;Blood Advances;2022-05-27